SAN FRANCISCO & ROCHESTER, Minn.--(BUSINESS WIRE)--Abridge has finalized an enterprise-wide agreement with Mayo Clinic to implement the AI-powered clinical documentation platform, starting with approximately 2,000 clinicians who serve over 1 million patients annually across a wide range of specialties and care settings.
This marks a significant expansion in the collaboration between Mayo Clinic and Abridge, building on the previously announced initiative to enhance nursing documentation workflows, which are being developed as part of the Epic workshop program.*
“At Mayo Clinic, we are committed to leveraging innovative AI platforms to improve both clinicians' well-being and provide high-quality, patient-centered care,” said Dr. Amy Williams, Executive Dean, Practice, Mayo Clinic. “This collaboration aims to enhance our continuous innovation and empowers our clinicians to focus on what matters most–our patients.”
During the evaluation process, Mayo Clinic performed a rigorous clinical note quality assessment to ensure that notes generated by Abridge would meet the high standards that Mayo Clinic maintains.
“This expansion reflects a shared mission to ease administrative burden, ultimately enabling both physicians and nurses to dedicate more attention to focused patient care,” said Dr. Shiv Rao, CEO and Founder of Abridge. “Mayo Clinic’s ethos for adopting high-quality innovation complements our drive to continuously enhance our platform to meet the unique needs of clinicians across diverse specialties, languages, and care settings.”
Abridge is rapidly becoming the platform of choice for enterprise-wide deployment at leading healthcare systems across the country, including Johns Hopkins Medicine, Corewell Health, Deaconess Health System, Reid Health, University of Vermont Health Network, CHRISTUS Health, UChicago Medicine, Sutter Health, Yale New Haven Health System, UCI Health, Emory Healthcare, The University of Kansas Health System, UPMC, and many more. Abridge has also formed partnerships with Wolters Kluwer, OpenNotes, and other leading healthcare organizations to enrich the Abridge platform ecosystem. In early 2024, Abridge announced a $150M Series C financing, which included a strategic investment from NVIDIA.
About Abridge
Abridge was founded in 2018 to power deeper understanding in healthcare. The AI-powered platform was purpose-built for medical conversations, improving clinical documentation efficiencies while enabling clinicians to focus on what matters most—their patients. With support for 28+ languages and 50+ specialties, Abridge is able to support a wide range of clinician and patient encounters.
Abridge’s enterprise-grade technology transforms patient-clinician conversations into structured clinical notes in real-time with deep EMR integrations. Powered by Linked Evidence and their auditable AI, Abridge is the only company that maps AI-generated summaries to ground truth, helping providers quickly trust and verify the output. As pioneers in generative AI for healthcare, Abridge is setting the industry standards for the responsible deployment of AI across health systems. Abridge was also recently recognized on the 2024 Forbes AI 50 list, alongside companies like OpenAI, Anthropic, Databricks, and others.
*Epic is a registered trademark of Epic Systems Corporation.
